Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
03/2005
03/17/2005US20050058999 Gene involved in apoptosis regulation
03/17/2005US20050058730 Dry powdered extract from medicinal herbs mixed with vitamins, minerals, sheep liver and/or carrot root; health foods, cakes, candy, bread, chocolate
03/17/2005US20050058716 Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
03/17/2005US20050058715 Composition containing a marine-derived inorganic substance and chitin/chitosan, and method of producing the composition
03/17/2005US20050058664 Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epitopes specific for classic-and variant IBDV strains
03/17/2005US20050058657 Vaccines for treatment of Aids
03/17/2005US20050058647 Newly identified polypeptide and polynucleotides for diagnosis of new compounds
03/17/2005US20050058641 Tolerance induction and maintenance in hematopoietic stem cell allografts
03/17/2005US20050058633 Stem cells that transform to beating cardiomyocytes
03/17/2005US20050058632 Cell carrier and cell carrier containment devices containing regenerative cells
03/17/2005US20050058631 Diagnosis, therapy; conditioning culture
03/17/2005US20050058630 Homogeneity culture product; promoting cell differentiation; thrombosis; antiinflammatory agents; immunosuppressants; antiapoptosis agents
03/17/2005US20050058629 Soft tissue repair and regeneration using postpartum-derived cells
03/17/2005US20050058628 Nuclear reprogramming of cells for therapeutic use
03/17/2005US20050058623 Use of gp130 activators in diabetic neuropathy
03/17/2005US20050058622 Preconditioning, ablation compound such as interleukins, colony stimulating factor
03/17/2005US20050056291 Engineering of adipose tissue by transplantation, augmentation or regeneration
03/17/2005CA2537995A1 Compositions and methods for inhibiting white spot syndrome virus (wssv) infection
03/17/2005CA2536934A1 Method for differentiating mesenchymal stem cell into hepatocyte and artificial human hepatocyte
03/16/2005EP1514937A1 Production of vaccines
03/16/2005EP1514556A1 Botulinum toxin pharmaceutical compositions
03/16/2005EP1514554A1 Oral composition based on natural substances useful in the maintenance of the correct hydration of the skin
03/16/2005EP1514553A1 Lactic acid bacteria powder double-coated using protein and polysaccharide and method preparing the same and a dosage form thereof
03/16/2005EP1514552A1 Novel fused imidazole derivative
03/16/2005EP1514482A1 Milk fractions and milk preparations for treating and/or preventing COX-2 mediated diseases
03/16/2005EP1513941A2 Preparation of microbial oil containing polyunsaturated fatty acids
03/16/2005EP1513928A2 A bank of stem cells for producing cells for transplantation having hla antigens matching those of transplant recipients, and methods for making and using such a stem cell bank
03/16/2005EP1513927A2 Generation of histocompatible tissues using nuclear transplantation
03/16/2005EP1513922A1 Pasteurisation process for microbial cells and microbial oil
03/16/2005EP1513921A1 A method of cell therapy using fused cell hybrids
03/16/2005EP1513550A2 Novel bacterium for treatment of disease
03/16/2005EP1513545A2 Methods and means to promote gut absorption
03/16/2005EP1513541A2 Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract
03/16/2005EP1513416A1 Mammalian animal compositon
03/16/2005EP1513404A1 Intramyocardial injection of autologous bone marrow
03/16/2005EP1268784B1 Genes involved in intestinal inflammatory diseases and use thereof
03/16/2005EP1250358B1 Therapeutic peptides
03/16/2005EP1037923B1 Method for preparing by filtration a virally secure factor viii solution
03/16/2005EP0952772B1 Methods of use of mononuclear phagocytes to promote axonal regeneration
03/16/2005EP0861329B1 Dodecahedral adenoviral protein complex, composition containing same and uses thereof
03/16/2005EP0769917B2 Nervonic acid compositions
03/16/2005CN1596305A Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
03/16/2005CN1596303A Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
03/16/2005CN1596126A 疫苗 Vaccine
03/16/2005CN1596124A Delivery system for biological component
03/16/2005CN1594556A Bone marrow mononuclear cell infected by recombinant co-gene adeno-associated virus and use thereof
03/16/2005CN1594357A Immune regulatory gene extracting method and use in preparation of drug for treating barrenness
03/16/2005CN1593666A Preparation method of therapy used iodine-125 sealed seed source core
03/16/2005CN1593647A Nutrient and healthy capsule of active ass hide
03/16/2005CN1593467A Method for extracting medicinal and edible substance from dictyoptera
03/16/2005CN1593466A Simple prescription of earthworm oral liquid for treating alveolar bone resorption and its preparing method
03/16/2005CN1593465A Soft capsule of forest frog oil and its preparation method
03/16/2005CN1593464A Healthy product extracted from barnacle and its preparation process
03/16/2005CN1593463A Method for preparing placenta extract and its application
03/16/2005CN1593462A Insulin secretory cell extract and its application in inducing stem cell differentiation
03/16/2005CN1593461A Nutrient oral liquor of ass hide glue flavone
03/16/2005CN1593460A Nutrient capsule of ass hide glue flavone
03/16/2005CN1593223A Active nutritious health oral liquid of donkey-hide gelatin
03/16/2005CN1593222A Function inducing nutritious powder for house fly larva and its preparation method
03/16/2005CN1193094C Antigenic proteins of shrimp white spot syndrome virus and uses thereof
03/16/2005CN1192798C Vaccine
03/16/2005CN1192790C Sugar-reducing capsule and its preparation method
03/16/2005CN1192788C Medicine for resisting allergic reaction and its preparation method
03/16/2005CN1192786C Women's beautifying health care medicine
03/16/2005CN1192782C Production method of injection used fortreating cardio and cerebro vascular diseases and its product
03/16/2005CN1192781C Virus-free plasma protein compositions treated with porous membrane and process for producing the same
03/16/2005CN1192719C Health-care food for preventing electronic pollution
03/15/2005US6867347 Transplantation of cells into humans; obtain cells, transform cells, graft cells into human, monitor human for defective phenotype
03/15/2005US6867334 Treating mammalian leukemia; lung carcinoma; colon adenocarcinoma malignant melanoma; assaying the human cytochrome CYP3A4 metabolism of ecteinascidin 743
03/15/2005US6867285 Removing contaminant viruses efficiently almost without losing the activity of protein using porous membrane; producing a fibrinogen composition substantially free of non-enveloped viruses, Parvovirus among others
03/15/2005US6867041 Simultaneous stimulation and concentration of cells
03/15/2005US6867033 By administration of PV virus-like particles (VLPs) to a patient suffering from the PV infection
03/15/2005US6866992 Aqueous solution comprising sodium chloride, sodium citrate, sodium acetate, sodium phosphate and a psoralen; stoichiometry, nonsettling of psoralen
03/15/2005US6866868 Reducing cleaning frequency of processing equipment used for capsulating egg derived products; eliciting lymphocyte mediated immune response
03/15/2005US6866853 Engineering live attenuated viruses which contain a modified nonstructural gene segment; influenza vaccines
03/15/2005US6866846 Extracting body fluid containing immune complexes relevant to immunopathological condition; complexing with adsorbent; elution; fractionating, immobilization onto biocompatible carriers activated to bond to its surface
03/15/2005US6866843 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
03/15/2005US6866668 Methods, instruments and materials for chondrocyte cell transplantation
03/15/2005CA2068069C Blood coagulation factor xi concentrate having high specific activity, suitable for therapeutic use, and process for preparing same
03/10/2005WO2005021738A1 Kidney derived stem cells and methods for their isolation, differentiation and use
03/10/2005WO2005021734A2 Generation of hematopoietic chimerism and induction of central tolerance
03/10/2005WO2005021706A2 Delivery of compounds with rehydrated blood cells
03/10/2005WO2005021575A2 Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties
03/10/2005WO2005021014A1 Preparation of biological amnion preservable at room temperature
03/10/2005WO2005020916A2 Myoblast treatment of diseased or weakened organs
03/10/2005WO2005020847A2 Graft materials containing bioactive substances, and methods for their manufacture
03/10/2005WO2004112806A8 Composition for treating or preventing neural disorders
03/10/2005WO2004103285A3 Lactoferrin in the treatment of diabetes mellitus
03/10/2005WO2004096972A3 Apparatus and methods for amplification of blood stem cell numbers
03/10/2005WO2004092348A3 Method for production of oncolytic adenoviruses
03/10/2005WO2004090112A3 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
03/10/2005WO2004026244A3 Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
03/10/2005WO2003076570A3 Antigens and their use as diagnostics and vaccines against species of plasmodium
03/10/2005WO2002094989A3 Retroviral vectors and methods of using same
03/10/2005US20050054820 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy
03/10/2005US20050054621 Fractionation of phytosterol esters in oil
03/10/2005US20050054595 Genetic engineering; gene expression of target agent
03/10/2005US20050054594 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
03/10/2005US20050054592 Alzheimer's disease; Parkinson's disease; isolated nucleic acids
03/10/2005US20050054575 Peptide agonists of prostate-specific antigen and uses therefor